The former was injected by tail vein with primary Notch1 induced murine T-ALL cells and the latter was inoculated subcutaneously with primary human T-ALL cells from T-ALL patients no matter there was Notch mutation or not. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.